ALKERMES | ALKS - Assets

ALKERMES reported $1.96B in Assets for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Assets Change
Acadia Pharmaceuticals ACAD:US USD 587.81M 14.68M
Acorda Therapeutics ACOR:US USD 395.6M 2.26M
Amgen AMGN:US USD 65.12B 1.42B
Biogen BIIB:US USD 24.55B 300.1M
Biomarin Pharmaceutical BMRN:US USD 6.38B 111.03M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Coherus Biosciences CHRS:US USD 480.85M 70.06M
Gilead Sciences GILD:US USD 63.17B 614M
Heron Therapeutics HRTX:US USD 250.95M 21M
Horizon Pharma HZNP:US USD 9.11B 86.75M
Intra Cellular Therapies ITCI:US USD 754.78M 27.22M
IONIS PHARMACEUT IONS:US USD 2.53B 111.9M
JAZZ PHA JAZZ:US USD 10.84B 450.59M
Marinus Pharmaceuticals MRNS:US USD 259.52M 74.68M
Minerva Neurosciences NERV:US USD 55.09M 4.67M
Nektar Therapeutics NKTR:US USD 710.6M 70.41M
Neurocrine Biosciences NBIX:US USD 2.37B 225.3M
Otsuka Holdings 4578:JP JPY 3.1T 85.02B
Regeneron Pharmaceuticals REGN:US USD 29.21B 1.54B
Revance Therapeutics RVNC:US USD 581.9M 129.69M
Teva Pharmaceutical Industries TEVA:US USD 44.01B 246M
Vertex Pharmaceuticals VRTX:US USD 18.15B 1.44B